<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02005809</url>
  </required_header>
  <id_info>
    <org_study_id>2nd look EGD</org_study_id>
    <nct_id>NCT02005809</nct_id>
  </id_info>
  <brief_title>Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm</brief_title>
  <acronym>SLEGD</acronym>
  <official_title>Clinical Impact of Second-look Endoscopy After Endoscopic Submucosal Dissection of Gastric Neoplasm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kosin University Gospel Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kosin University Gospel Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Gastroenterologists often follow up second look endoscopy after endoscopic submucosal
      dissection(ESD) of gastric neoplasms because they want to prevent bleeding of procedure
      sites. But Goto suggested in his retrospective analysis that a second-look endoscopy after
      endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary. So, the
      investigators try to identify the hypothesis prospectively in this study.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-ESD bleeding rate according to second look endoscopy</measure>
    <time_frame>Up to 60days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>bleeding complication rate according to location of lesion in stomach.</measure>
    <time_frame>Up to 60days</time_frame>
    <description>Fundus, cardia, upper body, mid body, lower body, antrum anterior wall, posterior wall, great curvature, lesser curvature</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding rate according to size of resected specimen</measure>
    <time_frame>Up to 60days</time_frame>
    <description>longest diameter of specimen: millimeter</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post ESD bleeding rate according to total procedure time of endoscopic submucosal dissection</measure>
    <time_frame>Up to 60days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post ESD bleeding rate according to bleeding degree during endoscopic submucosal dissection</measure>
    <time_frame>Up to 60days</time_frame>
    <description>Mild: bleeding control time: &lt;1/3 of total ESD procedure time. Moderate: bleeding control time: 1/3~1/2 of total ESD procedure time Severe: bleeding control time: &gt;1/2 of total ESD procedure time</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">268</enrollment>
  <condition>Gastric Neoplasms</condition>
  <arm_group>
    <arm_group_label>Second look endoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>This group is performed second look endoscopy about 24 hours later from endoscopic submucosal dissection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>without second look endoscopy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>This group is not performed second look endoscopy after ESD</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>second look endoscopy</intervention_name>
    <description>Second look endoscopy includes observation or prophylactic bleeding control of ESD site.</description>
    <arm_group_label>Second look endoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  histological confirmed patients(gastric adenoma or adenocarcinoma)

          -  performed gastric ESD patients about 24 hours before

        Exclusion Criteria:

          -  perforation after ESD

          -  piecemeal resection of ESD specimen

          -  hemostatic agent or proton pump inhibitor users before ESD

          -  heparin or antiplatelet agent users

          -  Serious concurrent infection or nonmalignant illness that is uncontrolled

          -  Psychiatric disorder that would preclude compliance

          -  Allergy history to proton pump inhibitor
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Moo In Park, MD</last_name>
    <phone>82519905061</phone>
    <email>myjuyoung@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kosin University Gospel Hospital</name>
      <address>
        <city>Busan</city>
        <zip>602-702</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>KiHwan Ku, MD</last_name>
      <phone>82519905209</phone>
      <email>lci7ku@naver.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S. New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy. 2001 Mar;33(3):221-6.</citation>
    <PMID>11293753</PMID>
  </reference>
  <reference>
    <citation>Takeshita K, Tani M, Inoue H, Saeki I, Honda T, Kando F, Saito N, Endo M. A new method of endoscopic mucosal resection of neoplastic lesions in the stomach: its technical features and results. Hepatogastroenterology. 1997 Nov-Dec;44(18):1602-11.</citation>
    <PMID>9427030</PMID>
  </reference>
  <reference>
    <citation>Goto O, Fujishiro M, Kodashima S, Ono S, Niimi K, Hirano K, Yamamichi N, Koike K. A second-look endoscopy after endoscopic submucosal dissection for gastric epithelial neoplasm may be unnecessary: a retrospective analysis of postendoscopic submucosal dissection bleeding. Gastrointest Endosc. 2010 Feb;71(2):241-8. doi: 10.1016/j.gie.2009.08.030. Epub 2009 Nov 17.</citation>
    <PMID>19922919</PMID>
  </reference>
  <reference>
    <citation>Tsuji Y, Ohata K, Ito T, Chiba H, Ohya T, Gunji T, Matsuhashi N. Risk factors for bleeding after endoscopic submucosal dissection for gastric lesions. World J Gastroenterol. 2010 Jun 21;16(23):2913-7.</citation>
    <PMID>20556838</PMID>
  </reference>
  <reference>
    <citation>Takizawa K, Oda I, Gotoda T, Yokoi C, Matsuda T, Saito Y, Saito D, Ono H. Routine coagulation of visible vessels may prevent delayed bleeding after endoscopic submucosal dissection--an analysis of risk factors. Endoscopy. 2008 Mar;40(3):179-83. doi: 10.1055/s-2007-995530.</citation>
    <PMID>18322872</PMID>
  </reference>
  <reference>
    <citation>Kim JW, Kim HS, Park DH, Park YS, Jee MG, Baik SK, Kwon SO, Lee DK. Risk factors for delayed postendoscopic mucosal resection hemorrhage in patients with gastric tumor. Eur J Gastroenterol Hepatol. 2007 May;19(5):409-15.</citation>
    <PMID>17413293</PMID>
  </reference>
  <reference>
    <citation>Uedo N, Takeuchi Y, Yamada T, Ishihara R, Ogiyama H, Yamamoto S, Kato M, Tatsumi K, Masuda E, Tamai C, Yamamoto S, Higashino K, Iishi H, Tatsuta M. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial. Am J Gastroenterol. 2007 Aug;102(8):1610-6. Epub 2007 Mar 31.</citation>
    <PMID>17403076</PMID>
  </reference>
  <reference>
    <citation>Chung IK, Lee JH, Lee SH, Kim SJ, Cho JY, Cho WY, Hwangbo Y, Keum BR, Park JJ, Chun HJ, Kim HJ, Kim JJ, Ji SR, Seol SY. Therapeutic outcomes in 1000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD Study Group multicenter study. Gastrointest Endosc. 2009 Jun;69(7):1228-35. doi: 10.1016/j.gie.2008.09.027. Epub 2009 Feb 27.</citation>
    <PMID>19249769</PMID>
  </reference>
  <reference>
    <citation>Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, Kato Y. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000 Dec;3(4):219-225.</citation>
    <PMID>11984739</PMID>
  </reference>
  <reference>
    <citation>Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001 Feb;48(2):225-9.</citation>
    <PMID>11156645</PMID>
  </reference>
  <reference>
    <citation>Fujishiro M, Kodashima S, Goto O, Ono S, Muraki Y, Kakushima N, Omata M. Technical feasibility of endoscopic submucosal dissection of gastrointestinal epithelial neoplasms with a splash-needle. Surg Laparosc Endosc Percutan Tech. 2008 Dec;18(6):592-7. doi: 10.1097/SLE.0b013e318187973f.</citation>
    <PMID>19098667</PMID>
  </reference>
  <reference>
    <citation>Shimatani T, Inoue M, Kuroiwa T, Xu J, Tazuma S, Horikawa Y, Nakamura M. Acid-suppressive efficacy of a reduced dosage of rabeprazole: comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry. Dig Dis Sci. 2005 Jul;50(7):1202-6.</citation>
    <PMID>16047460</PMID>
  </reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 26, 2013</study_first_submitted>
  <study_first_submitted_qc>December 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2013</study_first_posted>
  <last_update_submitted>December 4, 2013</last_update_submitted>
  <last_update_submitted_qc>December 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 9, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kosin University Gospel Hospital</investigator_affiliation>
    <investigator_full_name>Park Moo In</investigator_full_name>
    <investigator_title>Department of internal medicine, Kosin University Gospel Hospital</investigator_title>
  </responsible_party>
  <keyword>Endoscopic submucosal dissection</keyword>
  <keyword>gastric neoplasm</keyword>
  <keyword>second look endoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

